Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03809624
Title Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer (PDL1x41BB)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Inhibrx, Inc.
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST